ADVANCE MPI 2: Study of Regadenoson Versus Adenoscan® in Patients Undergoing Myocardial Perfusion Imaging (MPI)

NCT00208312 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

787

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Regadenoson
DRUG: Adenosine

Sponsor

Gilead Sciences

Collaborators

[object Object]